Janus Henderson Global Life Science... (JNGLX)
$66.58
-0.34 (-0.51%)
Rating:
Recommendation:
-
| Symbol | JNGLX |
|---|---|
| Price | $66.58 |
| Beta | 0.700 |
| Volume Avg. | - |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 59.07-70.85 |
| 1y Target Est | - |
| DCF Unlevered | JNGLX DCF -> | |
|---|---|---|
| DCF Levered | JNGLX LDCF -> | |
| ROE | - | |
| ROA | - | |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | - | |
| P/B | - |
About
Download (Excel)The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.